INDIA PATENTS

The US International Trade Commission is investigating Adani Solar USA and Adani Green Energy Ltd India for alleged patent infringement. The complaint, filed by Trina Solar, claims the Adani companies violated patents on solar cells, modules, and pa...

More expertise in artificial intelligence and quantum computing is needed from talents for career readiness said a set of panellists at the Bengaluru Tech Summit 2024. “The AI patents filed until the beginning of 2023, 60% came from China, 20% from ...

Grow Digi, a blockchain technology startup, has developed a technology that improves their application by reducing transaction time, lowering data storage requirements, and enhancing security. "We have been granted two patents from the government's ...

India has achieved a top-10 global ranking in patent, trademark, and industrial design filings. The country saw a 6.1% rise in trademark applications in 2023, securing its position as the fourth highest globally. Domestic filers, particularly in sec...

India has experienced significant growth in intellectual property filings, with patents and industrial design filings doubling and trademarks increasing by 60% between 2018 and 2023. This surge has propelled India to 6th globally in patent filings, ...

Health groups and patient advocates are raising concerns over patent monopolies on rare disease drugs in India. They argue that these monopolies, like the one held by Roche for the spinal muscular atrophy drug Risdiplam, restrict access to affordabl...

Royal Enfield unveiled its first electric motorcycle, The Flying Flea C6, under a new brand. Set to launch in spring 2026, the premium-priced motorcycle marks the company's foray into the EV market. Royal Enfield has been investing heavily in EV R&D...

In a statement, Nokia's Chief Licensing Officer Arvin Patel said the Munich Regional Court ruled Amazon was using "Nokia's patented video-related technologies in its end-user streaming devices and is selling them illegally without a licence".

Lupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialise Vonoprazan tablets in India. The drug, approved for various gastrointestinal conditions, will be marketed as Lupivon in 10 mg and 20 mg strengt...

Panacea Biotec has settled a patent dispute with Sanofi Healthcare India, leading to a rise in its stock. The Delhi High Court case involved Panacea's claim that Sanofi's Shan6 vaccine infringed on its EasySix patent. Sanofi agreed not to market the...

Panacea Biotec has settled a patent infringement case with Sanofi Healthcare India over a hexavalent vaccine. Sanofi will not launch its Shan6 vaccine in India and will withdraw its opposition to Panacea's patent. Panacea will forgo claims for damag...

For Indian pharmaceutical companies, this scenario presents a distinct opportunity. Leveraging their established expertise and leadership in global COVID-19 vaccine distribution, along with robust supply chain efficiencies, Indian firms are strategi...

Pharma stocks have surged due to a 'Patent Cliff,' where numerous drug patents expire, allowing generic manufacturers, especially in India, to produce cheaper versions. This trend is causing a revenue drop for original drug makers but presents growt...

Reliance Industries Chairman Mukesh Ambani announced Jio's major impact on global data traffic, carrying nearly 8% of it. He highlighted Jio's affordable services, noting data costs are just 10% of those in developed countries. With 490 million user...

India's telecommunications sector set a three-year goal to capture 10% of future global 6G patents. Chaired by Minister Jyotiraditya Scindia, the panel also discussed contributing significantly to global telecom standards, emphasizing the need for b...

Indian telecom companies aimed for 10% of 6G patents and substantial global standards contributions within three years, aligning research to national needs. This was discussed in a meeting chaired by telecom minister Jyotiraditya Scindia. Industry l...

India currently consumes around 3.2 million tonne of coated steel each year, he told ET, adding that the demand for this product from the value-added segment is growing at a faster pace than that of steel.

Mayne Pharma sued India's Sun Pharma for allegedly infringing patents on IMVEXXY, a drug for menopause-related vaginal pain. The lawsuit was filed after Sun Pharma sought FDA approval for a generic version. This action might delay FDA approval for S...

The Organisation of Pharmaceutical Producers of India (OPPI) is requesting exemptions for patented and orphan drugs from government price controls. They argue that current regulations hinder innovation and want more control over pricing post-patent ...